Afrobeats star Adekunle Gold has spoken publicly about the stigma he endures as a person living with sickle‑cell disease. In a candid interview with media personality Angela Yee, the Nigerian vocalist, known for hits such as “Orente” and “Something Different,” described the way people react when he reveals his condition and recounted a painful crisis that brought him to the brink of despair.
Gold said that whenever he mentions his sickle‑cell diagnosis, many listeners look at him as if death is imminent. “They stare at me like I’m going to die any minute,” he told Yee, adding that the perception often adds to the emotional burden of managing a chronic illness.
The singer recalled a particularly severe episode when he was 20 years old. “I had the craziest crisis of my life,” he said. “I prayed for my life to end, and my mother, who usually rebukes me when I talk about death, didn’t even try to stop me that night.” He explained that the intensity of the pain left him feeling that death was the only logical escape.
Despite that harrowing experience, Gold emphasized his gratitude for surviving the disease and his determination to keep fighting. “I’m thankful to God for giving me another chance,” he said, noting that he now uses his platform to raise awareness about sickle‑cell disease and the misconceptions that surround it.
Adekunle Gold’s openness comes at a time when advocacy for sickle‑cell awareness is gaining momentum across Africa. The condition—characterised by painful vaso‑occlusive crises, anemia and a shortened lifespan—affects millions of Africans, yet many patients still face misunderstanding and social isolation. By sharing his personal story, the artist hopes to challenge stereotypes and encourage more supportive attitudes toward those living with the disease.
The interview has resonated with fans and health advocates alike, sparking discussions on social media about the need for better education, early diagnosis and access to treatment. Organizations such as the Sickle Cell Foundation Nigeria have welcomed Gold’s contribution, calling it a valuable step toward destigmatising the illness.
As Gold continues to tour and release new music, his message underscores a broader shift in the entertainment industry toward using celebrity influence for public‑health advocacy. Observers say his candidness may inspire other public figures to speak out, potentially accelerating policy attention and funding for sickle‑cell research and patient support services.
The conversation highlights both the personal challenges faced by individuals with sickle‑cell disease and the wider societal obstacles that persist. By turning his painful past into a platform for dialogue, Adekunle Gold adds his voice to a growing chorus demanding greater empathy, awareness and resources for those living with the condition.
